Evaluation the effect of atypical antipsychotic augmentation with Atomoxetine

Phase 2

Recruiting

• Conditions: Schizophrenia.; Schizophrenia

• Registration Number: IRCT20100520003979N9
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Detection of schizophrenia based on the diagnosis of a faculty psychiatrist and an psychiatrist assistant with a clinical interview based on DSM-5
Bold negative symptoms( PANSS negative symptom sub-scale score more than 15)
Not having liver disease
Suffering from the disease for more than a year
Age between 18 and 70 years.

Exclusion Criteria

Presence of Depression based on DSM-5 Clinical Interview
Presence of Bipolar disorder
Pregnant or lactating woman
Substance abuse during the last month
patients suffering from Attention Deficit Hyperactivity Disorder (ADHD)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ack of social interest. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Frivolity. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Anhedonia. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.;Loss of motivation. Timepoint: At the beginning of the treatment and at 4th and 8th weeks. Method of measurement: PANSS scale.